Literature DB >> 25907612

Regulation of RAF protein kinases in ERK signalling.

Hugo Lavoie1, Marc Therrien2.   

Abstract

RAF family kinases were among the first oncoproteins to be described more than 30 years ago. They primarily act as signalling relays downstream of RAS, and their close ties to cancer have fuelled a large number of studies. However, we still lack a systems-level understanding of their regulation and mode of action. The recent discovery that the catalytic activity of RAF depends on an allosteric mechanism driven by kinase domain dimerization is providing a vital new piece of information towards a comprehensive model of RAF function. The fact that current RAF inhibitors unexpectedly induce ERK signalling by stimulating RAF dimerization also calls for a deeper structural characterization of this family of kinases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25907612     DOI: 10.1038/nrm3979

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  246 in total

1.  Activation of Raf-1 by 14-3-3 proteins.

Authors:  W J Fantl; A J Muslin; A Kikuchi; J A Martin; A M MacNicol; R W Gross; L T Williams
Journal:  Nature       Date:  1994-10-13       Impact factor: 49.962

2.  The amino-terminal B-Raf-specific region mediates calcium-dependent homo- and hetero-dimerization of Raf.

Authors:  Kenta Terai; Michiyuki Matsuda
Journal:  EMBO J       Date:  2006-07-20       Impact factor: 11.598

3.  Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259.

Authors:  Amardeep S Dhillon; Claire Pollock; Helge Steen; Peter E Shaw; Harald Mischak; Walter Kolch
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

4.  BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma.

Authors:  E Elizabeth Patton; Hans R Widlund; Jeffery L Kutok; Kamden R Kopani; James F Amatruda; Ryan D Murphey; Stephane Berghmans; Elizabeth A Mayhall; David Traver; Christopher D M Fletcher; Jon C Aster; Scott R Granter; A Thomas Look; Charles Lee; David E Fisher; Leonard I Zon
Journal:  Curr Biol       Date:  2005-02-08       Impact factor: 10.834

Review 5.  The underappreciated role of allostery in the cellular network.

Authors:  Ruth Nussinov; Chung-Jung Tsai; Buyong Ma
Journal:  Annu Rev Biophys       Date:  2013-02-28       Impact factor: 12.981

6.  Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation.

Authors:  Tomoko Kobayashi; Yoko Aoki; Tetsuya Niihori; Hélène Cavé; Alain Verloes; Nobuhiko Okamoto; Hiroshi Kawame; Ikuma Fujiwara; Fumio Takada; Takako Ohata; Satoru Sakazume; Tatsuya Ando; Noriko Nakagawa; Pablo Lapunzina; Antonio G Meneses; Gabriele Gillessen-Kaesbach; Dagmar Wieczorek; Kenji Kurosawa; Seiji Mizuno; Hirofumi Ohashi; Albert David; Nicole Philip; Afag Guliyeva; Yoko Narumi; Shigeo Kure; Shigeru Tsuchiya; Yoichi Matsubara
Journal:  Hum Mutat       Date:  2010-03       Impact factor: 4.878

7.  Pks, a raf-related sequence in humans.

Authors:  G E Mark; T W Seeley; T B Shows; J D Mountz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

8.  H-Ras forms dimers on membrane surfaces via a protein-protein interface.

Authors:  Wan-Chen Lin; Lars Iversen; Hsiung-Lin Tu; Christopher Rhodes; Sune M Christensen; Jeffrey S Iwig; Scott D Hansen; William Y C Huang; Jay T Groves
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-10       Impact factor: 11.205

9.  cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway.

Authors:  M R Vossler; H Yao; R D York; M G Pan; C S Rim; P J Stork
Journal:  Cell       Date:  1997-04-04       Impact factor: 41.582

10.  Identification of Raf-1 Ser621 kinase activity from NIH 3T3 cells as AMP-activated protein kinase.

Authors:  A B Sprenkle; S P Davies; D Carling; D G Hardie; T W Sturgill
Journal:  FEBS Lett       Date:  1997-02-24       Impact factor: 4.124

View more
  206 in total

1.  Knock-in(g) RAF for a loop.

Authors:  Andrea Varga; Manuela Baccarini
Journal:  EMBO J       Date:  2015-12-15       Impact factor: 11.598

2.  An FGFR inhibitor converts the tumor promoting effect of TGF-β by the induction of fibroblast-associated genes of hepatoma cells.

Authors:  H-R Zhang; X-D Wang; X Yang; D Chen; J Hao; R Cao; X-Z Wu
Journal:  Oncogene       Date:  2017-03-06       Impact factor: 9.867

3.  Systematic evaluation of the microRNAome through miR-CATCHv2.0 identifies positive and negative regulators of BRAF-X1 mRNA.

Authors:  Andrea Marranci; Romina D'Aurizio; Sebastian Vencken; Serena Mero; Elena Guzzolino; Milena Rizzo; Letizia Pitto; Marco Pellegrini; Giovanna Chiorino; Catherine M Greene; Laura Poliseno
Journal:  RNA Biol       Date:  2019-04-19       Impact factor: 4.652

4.  Time-resolved Phosphoproteome Analysis of Paradoxical RAF Activation Reveals Novel Targets of ERK.

Authors:  Peter Kubiniok; Hugo Lavoie; Marc Therrien; Pierre Thibault
Journal:  Mol Cell Proteomics       Date:  2017-02-10       Impact factor: 5.911

5.  Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion.

Authors:  Christopher R McEvoy; Huiling Xu; Kortnye Smith; Dariush Etemadmoghadam; Huei San Leong; David Y Choong; David J Byrne; Amir Iravani; Sophie Beck; Linda Mileshkin; Richard W Tothill; David D Bowtell; Bindi M Bates; Violeta Nastevski; Judy Browning; Anthony H Bell; Chloe Khoo; Jayesh Desai; Andrew P Fellowes; Stephen B Fox; Owen Wj Prall
Journal:  J Clin Invest       Date:  2019-03-05       Impact factor: 14.808

6.  MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation.

Authors:  Lingtao Jin; Jaemoo Chun; Chaoyun Pan; Dan Li; Ruiting Lin; Gina N Alesi; Xu Wang; Hee-Bum Kang; Lina Song; Dongsheng Wang; Guojing Zhang; Jun Fan; Titus J Boggon; Lu Zhou; Jeanne Kowalski; Cheng-Kui Qu; Conor E Steuer; Georgia Z Chen; Nabil F Saba; Lawrence H Boise; Taofeek K Owonikoko; Fadlo R Khuri; Kelly R Magliocca; Dong M Shin; Sagar Lonial; Sumin Kang
Journal:  Cancer Cell       Date:  2018-07-19       Impact factor: 31.743

Review 7.  Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations.

Authors:  Matthew Dankner; April A N Rose; Shivshankari Rajkumar; Peter M Siegel; Ian R Watson
Journal:  Oncogene       Date:  2018-03-15       Impact factor: 9.867

Review 8.  Two is better than one; toward a rational design of combinatorial therapy.

Authors:  Sheng-Hong Chen; Galit Lahav
Journal:  Curr Opin Struct Biol       Date:  2016-08-10       Impact factor: 6.809

Review 9.  The Mystery of Rap1 Suppression of Oncogenic Ras.

Authors:  Ruth Nussinov; Hyunbum Jang; Mingzhen Zhang; Chung-Jung Tsai; Anna A Sablina
Journal:  Trends Cancer       Date:  2020-03-02

10.  Activation loop phosphorylation regulates B-Raf in vivo and transformation by B-Raf mutants.

Authors:  Martin Köhler; Michael Röring; Björn Schorch; Katharina Heilmann; Natalie Stickel; Gina J Fiala; Lisa C Schmitt; Sandra Braun; Sophia Ehrenfeld; Franziska M Uhl; Thorsten Kaltenbacher; Florian Weinberg; Sebastian Herzog; Robert Zeiser; Wolfgang W Schamel; Hassan Jumaa; Tilman Brummer
Journal:  EMBO J       Date:  2015-12-10       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.